Rupee Steady At 82.35 As Dollar's Surge Eases, But Risks Remain
The rupee held steady on Monday as the dollar easedin a cautious open to the week.
Stay updated with breaking news from Surge Eases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The rupee held steady on Monday as the dollar easedin a cautious open to the week.
(Bloomberg) -- The omicron variant is starting to loosen its grip on the U.S. Northeast, but experts warn that it will take more time for the latest wave of Covid-19 to recede nationwide. Deaths in the U.S.
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 2/3/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) -- AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost produc...
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 3/02/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) -- AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost produ...
California, N.Y. to Open New Stadium Vaccine Sites: Virus Update Bloomberg 3/02/2021 Bloomberg News © Bloomberg People wearing protective masks wait in line to receive a dose of the Moderna Covid-19 vaccine at a walk up vaccination site in San Francisco, California, U.S., on Wednesday, Feb. 3, 2021. (Bloomberg) -- AstraZeneca Plc and the University of Oxford have started looking at how to re-engineer their coronavirus vaccine to defeat new mutations, saying a tweaked injection could be ready by autumn. GlaxoSmithKline Plc agreed to work with CureVac NV to help boost produ...